{
  "id": 14646302,
  "title": "Iambic snags $150M IPO for AI-driven cancer pipeline",
  "url": "https://urgent.news/2026/10/15/iambic-snags-150m-ipo-for-ai-driven-cancer-pipeline",
  "topic": "ai",
  "section": "AI",
  "published": "2026-10-15T08:01:53.000Z",
  "source": {
    "name": "Endpoints News",
    "slug": "endpoints-news",
    "url": "https://endpoints.news/iambic-snags-150m-ipo-for-ai-driven-cancer-pipeline/"
  },
  "original_language": "en",
  "account": null,
  "summary": "Nvidia-backed Iambic Therapeutics will begin trading Thursday after pricing its $150 million initial public offering Wednesday night. The cancer-focused biotech sold 9.38 million shares {$IAM} at $16 apiece. The float adds ...",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}